Nielsen Søren U, Bassendine Margaret F, Burt Alastair D, Bevitt Debra J, Toms Geoffrey L
School of Clinical Medical Sciences, Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.
School of Clinical and Laboratory Sciences, Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.
J Gen Virol. 2004 Jun;85(Pt 6):1497-1507. doi: 10.1099/vir.0.79967-0.
In the absence of satisfactory cell culture systems for hepatitis C virus (HCV), virtually all that is known about the proteins of the virus has been learned by the study of recombinant proteins. Characterization of virus proteins from patients with HCV has been retarded by the low virus titre in blood and limited availability of infected tissue. Here, the authors have identified a primary infection in a liver transplanted into an immunodeficient patient with chronic HCV. The patient required re-transplant and the infected liver, removed 6 weeks after the initial transplant, had a very high titre of HCV, 5 x 10(9) International Units (IU) per gram of liver. The density distribution of HCV in iodixanol gradients showed a peak at 1.04 g x ml(-1) with 73 % of virus below 1.08 g x ml(-1). Full-length HCV RNA was detected by Northern blotting and the ratio between positive- and negative-strand HCV RNA was determined as 60. HCV was partially purified by precipitation with heparin/Mn(2+) and a single species of each of the three structural proteins, core, E1 and E2, was detected by Western blotting. The molecular mass of core was 20 kDa, which corresponds to the mature form from recombinant sources. The molecular mass of glycoprotein E1 was 31 kDa before and 21 kDa after deglycosylation with PNGase F or endoglycosidase H. Glycoprotein E2 was 62 kDa before and 36 kDa after deglycosylation, but E2-P7 was not detected. This was in contrast to recombinant sources of E2 which contain E2-P7.
由于缺乏令人满意的丙型肝炎病毒(HCV)细胞培养系统,几乎所有关于该病毒蛋白质的知识都是通过对重组蛋白的研究获得的。HCV患者病毒蛋白的特性研究因血液中病毒滴度低和感染组织可用性有限而受到阻碍。在此,作者在移植到患有慢性HCV的免疫缺陷患者体内的肝脏中发现了一次原发性感染。该患者需要再次移植,在初次移植6周后切除的受感染肝脏中,HCV滴度非常高,每克肝脏有5×10⁹国际单位(IU)。碘克沙醇梯度中HCV的密度分布在1.04 g·ml⁻¹处出现峰值,73%的病毒低于1.08 g·ml⁻¹。通过Northern印迹法检测到全长HCV RNA,正链和负链HCV RNA的比例确定为60。通过肝素/Mn²⁺沉淀对HCV进行部分纯化,通过Western印迹法检测到三种结构蛋白(核心蛋白、E1蛋白和E2蛋白)中的每一种都有单一物种。核心蛋白的分子量为20 kDa,这与重组来源的成熟形式相对应。糖蛋白E1在使用PNGase F或内切糖苷酶H去糖基化之前分子量为31 kDa,之后为21 kDa。糖蛋白E2在去糖基化之前为62 kDa,之后为36 kDa,但未检测到E2-P7。这与含有E2-P7的重组E2来源形成对比。